FDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potential
FDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potential
Body unavailable. Use the original source.
FDA approves J&J's psoriasis pill Icotyde with $5B+ peak sales potential
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.